Jennifer Cann Views & Analysis Patient centricity in pharma: Predictions for 2020 and beyon... pharmaphorum's Jennifer Cann looks at what trends from 2019 tell us about the future of patient centricity and how pharma can prepare themselves for the coming changes.
Views & Analysis Patient centricity in pharma: Predictions for 2020 and beyon... pharmaphorum's Jennifer Cann looks at what trends from 2019 tell us about the future of patient centricity and how pharma can prepare themselves for the coming changes.
News Lily gets FDA nod for SERD-CDK 4/6 combo in breast cancer Eli Lilly's imlunestrant (Inluriyo) for breast cancer has received a new FDA approval, in combination with CDK4/6 inhibitor abemaciclib (Verzenio).
Digital Sponsored Discover a new era of healthcare panel engagement: Grounded ... A new webinar from Konovo will address some of the critical topics impacting today’s healthcare market research industry.
